Efficacy of digital therapeutics for perioperative management in patients with lung cancer: a randomized controlled trial.

ABSTRACT:

Background

Perioperative management and lung function recovery are vital for lung cancer patients. We conducted an open-label, single-center, noninferiority, randomized controlled trial in China to evaluate the efficacy of digital therapeutic (DTx)-assisted management vs. multidisciplinary management (MM) in the perioperative management of patients with lung cancer.

Methods

From July 2022 to June 2023, 186 minimally invasive lung surgery patients were randomized, and 147 completed the study. The participants were randomly assigned a 1:1 ratio to receive DTx-assisted management (n = 72) or traditional MM (n = 75). The primary endpoint was the pulmonary function recovery rate measured by forced expiratory volume in the first second (FEV1%) 3 weeks after surgery, and the noninf

SUBMITTER: Xu J 

PROVIDER: S-EPMC11951826 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature